Videos
Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, discusses specialty areas experiencing innovative developments in therapies.
Thom Cohn, Chief Strategy Officer, Asembia, discusses special considerations for the launch of a personalized drug.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Orforglipron Shows Strong Weight Maintenance in Phase 3 ATTAIN-MAINTAIN Trial
2
FDA Approves 1-Minute SC Mosunetuzumab for R/R Follicular Lymphoma
3
Pharmacist Takeover: A Day in the Life of an Oncology Pharmacist
4
Year in Review: FDA Expands Biosimilar Approvals Across Oncology, Immunology, and Bone Health
5